BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 742624)

  • 1. Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia type II.
    Hamilton BP; Landsberg L; Levine RJ
    Am J Med; 1978 Dec; 65(6):1027-32. PubMed ID: 742624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determining the rate of catecholamine excretion in the diagnosis of pheochromocytoma].
    Molchanova GS; Rogozhnikova EA
    Klin Med (Mosk); 1988 Feb; 66(2):97-102. PubMed ID: 3374060
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine.
    Smythe GA; Edwards G; Graham P; Lazarus L
    Clin Chem; 1992 Apr; 38(4):486-92. PubMed ID: 1568311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine suppression test in pheochromocytoma.
    Gáspár L; Kiss Z; Iványi T; Lászlé FA
    N Engl J Med; 1982 Jul; 307(3):189-90. PubMed ID: 7088062
    [No Abstract]   [Full Text] [Related]  

  • 5. Clues to the diagnosis of pheochromocytoma from the differential tissue metabolism of catecholamines.
    Eisenhofer G; Lenders JW
    Adv Pharmacol; 1998; 42():374-7. PubMed ID: 9327920
    [No Abstract]   [Full Text] [Related]  

  • 6. [Difficulties in the diagnosis of pheochromocytoma in the internal medicine practice].
    Podzolkov VI; Starovoĭtova SP; Mel'nichenko GA
    Ter Arkh; 1988; 60(7):133-5. PubMed ID: 3212729
    [No Abstract]   [Full Text] [Related]  

  • 7. Rigorous biochemical criteria for the diagnosis of pheochromocytoma.
    Freier DT; Harrison TS
    J Surg Res; 1973 Mar; 14(3):177-80. PubMed ID: 4702157
    [No Abstract]   [Full Text] [Related]  

  • 8. Dihydroxyphenylglycol in pheochromocytoma: its diagnostic use for norepinephrine dominant tumor.
    Nakada T; Sasagawa I; Kubota Y; Suzuki H; Ishigooka M; Watanabe M
    J Urol; 1996 Jan; 155(1):14-8. PubMed ID: 7490813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience.
    Gagel RF; Tashjian AH; Cummings T; Papathanasopoulos N; Kaplan MM; DeLellis RA; Wolfe HJ; Reichlin S
    N Engl J Med; 1988 Feb; 318(8):478-84. PubMed ID: 2893259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal catecholamine production in a patient with a paroxysmally secreting phaeochromocytoma.
    Sinclair D; Shenkin A; Lorimer AR
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():417-9. PubMed ID: 1892355
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary epinephrine and norepinephrine excretion in patients with medullary thyroid carcinoma and their relatives].
    Miyauchi A; Masuo K; Ogihara T; Takai S; Matsuzuka F; Kuma K; Maeda M; Kumahara Y; Kosaki G
    Nihon Naibunpi Gakkai Zasshi; 1982 Dec; 58(12):1505-16. PubMed ID: 7169098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Great Masquerador: A Young Female with Multiple Endocrine Neoplasia Type 2A and Bilateral Pheochromocytomas.
    Chua MWJ; Sek KS; Tai ES
    Am J Med; 2019 Nov; 132(11):e767-e770. PubMed ID: 31103648
    [No Abstract]   [Full Text] [Related]  

  • 13. Factitial epinephrine-only secreting pheochromocytoma.
    Brandenburg RO; Gutnik LM; Nelson RL; Abboud CF; Edis AJ; Sheps SG
    Ann Intern Med; 1979 May; 90(5):795-6. PubMed ID: 434686
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical study of pheochromocytoma.
    May AG; Moss A; Gutierrez OH; Burday SZ; Campbell RG
    Am J Surg; 1981 Mar; 141(3):346-52. PubMed ID: 7212182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of screening for phaeochromocytoma in 17 hypertensive patients with episodic symptoms.
    Hull RD; Sebel E; Stokes GS; Chalmers JP; Hinterberger H
    Med J Aust; 1974 Mar; 1(11):381-5. PubMed ID: 4829549
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative values of the assay of catecholamines, methoxyamines and vanilmandelic acid in the diagnosis of pheochromocytoma].
    Peyrin L; Mornex R; Cier JF
    Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():62-71. PubMed ID: 119514
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Broadsheet No 127: April 1991. Measurement of catecholamines and their metabolites in urine.
    Weinkove C
    J Clin Pathol; 1991 Apr; 44(4):269-75. PubMed ID: 2030143
    [No Abstract]   [Full Text] [Related]  

  • 18. Heart failure due to adrenergic myocardial toxicity from a pheochromocytoma.
    De Lazzari M; Cipriani A; Marra MP; Armanini D; Sabbadin C; Giorgi B; Iliceto S; Tona F
    Circ Heart Fail; 2015 May; 8(3):646-8. PubMed ID: 25991807
    [No Abstract]   [Full Text] [Related]  

  • 19. Pheochromocytoma in the modern context.
    Delarue NC; Morrow JD; Kerr JH; Colapinto RF
    Can J Surg; 1978 Sep; 21(5):387-94. PubMed ID: 31234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial occurrence of adrenaline-producing pheochromocytoma associated with medullar thyroid carcinoma].
    von Studnitz W; Ljungberg O
    Klin Wochenschr; 1970 Feb; 48(3):144-8. PubMed ID: 5523127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.